World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Top Court in India Rejects Novartis Drug Patent
Keywords:
Indian pharmaceutical companies and export markets.
02/09/2006
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/2016
In Trade Deal, a Shift on Generics
Wall Street Journal 05/17/2007
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
BusinessWeek 09/04/2008
Indian pharmaceutical companies and the growing demand in India.
02/09/2006
The rapidly growing Indian pharmaceutical companies. The Indian market $8 billion today will grow to $30 billion in the next 10 years as more people get access to better healthcare. Sales in the Middle East, Africa and Latin America, and outsourcing manufacture for western companies are additional sources of growth for these companies.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
India's exports- 2010-2013
07/25/2011
The shift in exports from textiles to automobiles, automotive, petrochemical, pharmaceutical and engineering goods. Manufactured goods at $245 billion for 2010 are now twice as large as IT services in India's exports.
Grouped Articles
Rupee Continues Decline on New Evidence of Weakness in Indian Economy
New York Times 09/02/2013
Manufactured Goods Lead Surge in Indian Exports
New York Times 07/25/2011
India-E.U. trade pact could boost AIDS treatment costs, health workers say - The Washington Post
Washington Post 02/11/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Rupee Plunges to an All-Time Low
Wall Street Journal 06/22/2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
Outsourcing production to India and China by pharmaceutical companies.
05/29/2007
FDA's efforts to ensure safety by inspecting facilities.
Grouped Articles
China Worries Could Hurt Pharma’s Health
Wall Street Journal 08/24/2015
China Sentences Former Drug Regulator to Death
New York Times 05/29/2007
China Faces a New Worry: Heavy Metals in the Food
Wall Street Journal 07/02/2007
China-Product Scare Hits Home, Too
Wall Street Journal 07/20/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
BusinessWeek 09/04/2008
Indian generic phamaceutical company Lupin
09/29/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Lupin Sees U.S. Generic-Drug Pickup
Wall Street Journal 09/29/2011
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
Pharmaceutical Generics.
10/22/2006
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
More Low-Cost Generics - WSJ.com
Wall Street Journal 10/22/2006
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03/14/2007
In Trade Deal, a Shift on Generics
Wall Street Journal 05/17/2007
Wall Street Journal 02/06/2008
Daiichi Targets Generics to Extend Reach
Wall Street Journal 06/12/2008
Pharmaceutical companies with Generics products are changing the marketplace.
07/26/2005
With growing demand for low cost affordable drugs the growth in sales of generics.
Grouped Articles
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Branded Drugs Settling More Generic Suits
Wall Street Journal 01/17/2006
Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain
Wall Street Journal 01/20/2006
As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future
Wall Street Journal 01/05/2006
Teva to Acquire Ivax, Another Maker of Generic Drugs
New York Times 07/26/2005
Wall Street Journal 07/26/2005
Indian pharmaceutical companies and patent challenges.
07/07/2009
Grouped Articles
India Orders Bayer to License Patented Cancer Drug
New York Times 03/12/2012
India Rejects Novartis Patent Claim
Wall Street Journal 07/07/2009
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
India-E.U. trade pact could boost AIDS treatment costs, health workers say - The Washington Post
Washington Post 02/11/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Indian pharmaceutical manufacturer Cipla
03/06/2012
Grouped Articles
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
India's Supreme Court and Novatis leukemia drug Gleevec
03/06/2012
The issues of what drugs are patentable in India,"evergreening" for patents, and public health concerns throughout developing countries, that are now before the Indian Supreme Court. India permitted the patenting of drugs only since 2005 under a WTO agreement, and there are restrictions on "evergreening," or small modifications of existing drugs for marketing. Novartis and other pharmaceutical companies aim to use the case to restrict Indian generic pharmaceuticals manufacturers from coming up with lowcost versions of new drugs. The leukemia treatment developed by Novartis costs over $70,000, by comparison Indian generic manufacturers can make a version of this for $2500.
Grouped Articles
India Orders Bayer to License Patented Cancer Drug
New York Times 03/12/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Three Days Of Hearings Yield Five Take-Aways
Wall Street Journal 03/29/2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
Intellectual property issues, pricing and the Indian pharmaceutical industry
02/11/2012
Grouped Articles
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
India-E.U. trade pact could boost AIDS treatment costs, health workers say - The Washington Post
Washington Post 02/11/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
Pharmaceutical companies fighting generics.
10/22/2006
Pharmaceutical compaies are trying to make it harder for pharmacists to substitute generics.
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Industry Fights Switch To Generics for Epilepsy
Wall Street Journal 07/13/2007
Wall Street Journal 02/06/2008
TriCor Case May Illuminate Patent Limits
Wall Street Journal 06/02/2008
How a Drug Maker Tries to Outwit Generics
Wall Street Journal 11/17/2008
Ending the Silence of Generic Drugmakers
BusinessWeek 06/24/2010
Price increases and cost of branded drugs and generic drugs- the pharmaceutical industry in 2011-2014
01/11/2010
Higer cost of specialty drugs for cancer, MS, other diseases, and the efforts by companies to squeeze profits from a shrinking branded portfolio push costs up for branded drugs. Prices of generics decline significantly. Express Scripts study shows 11% increase for branded drugs in 2011-2012 compared to 22% decrease for generics.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Will Rising Prices for Some Generic Drugs Never End?
Wall Street Journal 11/14/2014
Washington Post 09/22/2015
Cost of Brand-Name Prescription Medicines Soaring
New York Times 11/28/2012
Beneath Budget Battle, a Health-Spending Juggernaut
Wall Street Journal 12/17/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us